Search

Board

The EHA Board is the governing body of the association and deals with issues of policy. The Board sets the goals and objectives of the association in conformity with the EHA's statutes.

Read more

European Hematology Association tentatively responds to the European Commission’s proposal to improve clinical research

In addition, the regulation appears to accommodate multi-national trials with, for instance, a harmonized authorization dossier, and a single submission system.

Read more

The new EU clinical trials map is online

A new clinical trial map was launched by EMA as part of the Clinical Trials Information System (CTIS) on March 3.

Read more

EHA2024 Scientific Congress Report

The European Hematology Association (EHA) is delighted to present the EHA2024 Scientific Congress Report titled “EHA Perspectives on Emerging Technologies in Hematology.

Read more

Presidential Speakers

Promising crucial developments in the field of hematology, the speakers and presentation topics of the EHA2025 Presidential Session speakers are now available.  

Friday, June 13, 2025 - Presidential Session I

Immunotherapy (TCR related)

Prof.

Read more

GAPP Joint Action

Joint Actions are projects designed and financed by Member State Authorities and the EU to address specific priorities under the EU Health Program.

Read more